319 related articles for article (PubMed ID: 17763150)
21. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
[TBL] [Abstract][Full Text] [Related]
22. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
23. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
[TBL] [Abstract][Full Text] [Related]
24. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
25. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
26. Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation.
Lev EI; Solodky A; Harel N; Mager A; Brosh D; Assali A; Roller M; Battler A; Kleiman NS; Kornowski R
J Am Coll Cardiol; 2010 Jan; 55(2):114-21. PubMed ID: 20117379
[TBL] [Abstract][Full Text] [Related]
27. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.
Paniccia R; Antonucci E; Maggini N; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R
Am J Clin Pathol; 2009 Jun; 131(6):834-42. PubMed ID: 19461090
[TBL] [Abstract][Full Text] [Related]
28. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
[TBL] [Abstract][Full Text] [Related]
29. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
[TBL] [Abstract][Full Text] [Related]
31. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
[TBL] [Abstract][Full Text] [Related]
32. Shear-induced platelet aggregation in aspirin-treated patients: initial experience with the novel PlaCor PRT device.
Würtz M; Hvas AM; Wulff LN; Kristensen SD; Grove EL
Thromb Res; 2012 Nov; 130(5):753-8. PubMed ID: 22995532
[TBL] [Abstract][Full Text] [Related]
33. Effect of obesity on platelet reactivity and response to low-dose aspirin.
Bordeaux BC; Qayyum R; Yanek LR; Vaidya D; Becker LC; Faraday N; Becker DM
Prev Cardiol; 2010; 13(2):56-62. PubMed ID: 20377806
[TBL] [Abstract][Full Text] [Related]
34. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
[TBL] [Abstract][Full Text] [Related]
35. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
[TBL] [Abstract][Full Text] [Related]
36. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.
Cesar JM; de Miguel D; García Avello A; Burgaleta C
Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818
[TBL] [Abstract][Full Text] [Related]
37. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
[TBL] [Abstract][Full Text] [Related]
38. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
39. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
Pamukcu B; Oflaz H; Onur I; Oncul A; Umman B; Koylan N; Bugra Z; Meric M; Nisanci Y
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):461-5. PubMed ID: 17581321
[TBL] [Abstract][Full Text] [Related]
40. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.
Carroll RC; Craft RM; Snider CC; Aligeti VR; Wortham DC
Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]